Finerenone for type 2 diabetes with kidney disease
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is testing a medication called finerenone to see how well it helps people with type 2 diabetes who also have chronic kidney disease. Researchers are looking at how the drug affects kidney function and related health factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have type 2 diabetes with chronic kidney disease (moderate to severe kidney damage).
- Your diabetes and other medications have been stable for at least 3 months, with no planned changes.
- You are not taking certain medications that raise potassium or interact with the study drug.
- You do not have other serious health conditions like type 1 diabetes, poor blood sugar control, high blood pressure, high potassium, liver disease, or active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a medicine called finerenone can protect kidney function in people with type 2 diabetes and early-to-moderate chronic kidney disease. It may be an option if you are already on blood pressure medication and have some protein in your urine.
This observational study tracks how well finerenone (a kidney-protective medication) works in adults with type 2 diabetes and chronic kidney disease in Spain. Researchers will measure changes in kidney function and disease risk over time to better understand the medication's real-world benefits.
This study looks at how the medication finerenone works in everyday medical practice for people with type 2 diabetes and certain stages of chronic kidney disease. It aims to see how safe and effective the treatment is outside of a clinical trial setting.
This study is for people in South Korea who have chronic kidney disease and type 2 diabetes and are already taking or about to start the medicine finerenone (Kerendia). The goal is to see how well finerenone works in everyday medical care, outside of a strict research setting.
This study tests whether finerenone, a medication that protects the kidneys and heart, can help African American veterans with type 2 diabetes and early kidney damage. If you qualify, you may receive the study drug and close monitoring of your kidney function and blood sugar.
This trial tests whether adding finerenone to your current diabetes medications can better protect your heart and kidneys. It is for people with type 2 diabetes who already take an SGLT2 inhibitor and an ACE inhibitor or ARB.
Hear when a new Diabetic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.